Plasma Proteomic Profiling

Achieve unmatched profiling depth—5,400+ validated protein assays with superior specificity in one streamlined workflow.

Empower Proteomic Translational Success with Proven Profiling Solutions

The proteome’s intricate networks, temporal dynamics, and elusive low-abundance proteins often impede the path from protein biomarker discovery to clinical impact. Overcome these complexities and power your next breakthrough with Broad Clinical Labs’ Plasma Proteomic Profiling. Leveraging the high-throughput proteomic platform, Olink® Explore HT, we deliver targeted plasma proteomics with unprecedented profiling depth from liquid biopsy samples to accelerate disease understanding and drug development.

Fast-track your path from discovery to therapeutic impact and uncover what comprehensive plasma proteomics can reveal in your studies.

Plasma Proteomic Profiling Service

Achieve high-sensitivity, multiplexed quantification of 5,400+ plasma proteins from minimal sample volumes with our Olink® Explore HT service. This comprehensive profiling enables holistic biomarker discovery, accelerating clinical translation with precision.

Olink® Explore HT targets diverse protein categories including low-abundance inflammatory proteins, established drug targets, tissue-specific markers, and novel exploratory biomarkers across multiple research areas.

Protein categories addressed in the Olink® Explore HT assay

Research Applications

Drug Discovery & Development

Disease Research

Clinical Implementation

Powering Applications Beyond Plasma Proteomics

Combine proteomic profiles with genomic, transcriptomic, and metabolomic data for next-generation systems biology insights. This integrated multi-omics approach reveals complex biological relationships and regulatory mechanisms to achieve comprehensive disease characterization and therapeutic target identification.

Reliable Proteomic Profiling Solutions

Unparalleled Protein Coverage with Exceptional Specificity

The Olink® Explore HT platform combines innovate dual-recognition and Proximity Extension Assay (PEA) technologies to achieve industry-leading specificity that eliminates cross-reactivity and ensures data quality, with access to 5,400+ rigorously validated protein assays per sample.

High-Throughput Multiplexing Enables Scale

Our streamlined automated proteome analysis seamlessly scales from pilot studies to population-scale, while maintaining a gold standard in data reliability.

End-to-End Plasma Proteomics Research Services

Broad Clinical Lab’s Olink® Explore HT service includes sample preparation, Illumina® sequencing, and comprehensive proteomic data analysis using the Olink® NPX Explore HT software —providing normalized protein expression results and detailed reports delivered through secure digital transfer.

Plasma Proteomic Profiling with Broad Clinical Labs

Service Data Deliverables What’s Included

Plasma Proteomic Profiling

Analysis report and normalized protein expression (NPX) file with:

  • NPX values
  • Pass or fail QC
  • Intra & inter plate control QC
  • Sample preparation using the Olink® Explore HT kit
  • Illumina® sequencing
  • Analysis using Olink® NPX Explore HT software
  • Data delivery

Project Workflow: Plasma Proteomic Profiling Services

Project onboarding

Project onboarding
(contracting if required)

Regulatory Review
Quoting
Sample Kits

Sample intake and QC

Sample intake and QC

Inputs:
Human plasma in EDTA, citrate, or heparin tubes

Library Receipt at BCL

Library construction

Olink® Explore HT assay

Internal and external controls ensure data quality

Sequencing

Sequencing

Data generated using Illumina® Sequencing technology

Data delivery

Data and report delivery
(bioinformatic analysis optional)

Analysis report and NPX (normalized protein expression) file, sent as a parquet file

Project onboarding

Project onboarding
(contracting if required)

Regulatory Review
Quoting
Sample Kits

Sample intake and QC

Sample intake and QC
(extraction optional)

Inputs:
Human plasma in EDTA, citrate, or heparin tubes

Library Receipt at BCL

Library construction

Olink® Explore HT assay

Internal and external controls ensure data quality

Sequencing

Sequencing

Data generated using Illumina® Sequencing technology

Data delivery

Data and report delivery
(bioinformatic analysis optional)

Analysis report and NPX (normalized protein expression) file, sent as a parquet file

Frequently Asked Questions

What plasma proteomics service does Broad Clinical Labs offer?

Broad Clinical Labs Plasma Proteomic Profiling uses the Olink® Explore HT platform. It quantifies more than 5,400 validated protein assays per sample from minimal plasma volume. The assay combines dual-recognition and Proximity Extension Assay (PEA) technology for high specificity, with an Illumina® sequencing readout. Coverage spans low-abundance inflammatory proteins, established drug targets, tissue-specific markers, and exploratory biomarkers.

Broad Clinical Labs plasma proteomics accepts human plasma collected in EDTA, citrate, or heparin tubes. Deliverables include an analysis report and a normalized protein expression (NPX) file in parquet format. The file contains NPX values, pass/fail QC, and intra- and inter-plate control QC. Analysis uses Olink® NPX Explore HT software.

Plasma proteomics supports drug discovery and development, including protein biomarker identification, biomarker validation, and pharmacokinetic analyses. It also supports disease research such as protein network mapping and mechanism of action studies. At Broad Clinical Labs, the workflow scales from pilot studies to population-scale cohorts.

Plasma proteomics data can be integrated with genomic, transcriptomic, and metabolomic data for systems-level analysis of disease mechanisms and therapeutic targets. Broad Clinical Labs offers whole genome sequencing, RNA sequencing, and single cell sequencing alongside proteomics through its biomarker discovery platform.

As a CLIA-certified laboratory operating under the rigorous standards of the Broad Institute, Broad Clinical Labs is held to a level of oversight that directly protects you, your data, and your patients. Broad Clinical Labs protects your data inside a regulated security boundary built on NIST 800-53-compliant systems. Your data belongs to you and is returned to you. We do not sell participant data or use it beyond what is needed to deliver your services, and we retain only what regulatory obligations require.

Reach out to our specialists today to get started on your plasma proteomic profiling project.

Looking for a different solution? View our complete service portfolio.